Cargando…

Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Detalles Bibliográficos
Autores principales:	Saheb Kashaf, Sara, Godley, Lucy A., Chadha, Angad, Waldinger, Jason B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315773/ https://www.ncbi.nlm.nih.gov/pubmed/37405177 http://dx.doi.org/10.1016/j.jdcr.2023.04.007

Ejemplares similares

Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients
por: Bennedbæk, Marc, et al.
Publicado: (2016)

SAT-315 SDHC Germline Mutation Carrier with Primary Paraganglioma of the Thyroid Gland
por: Lee, Hyunju, et al.
Publicado: (2019)

Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
por: Andrews, Katrina A, et al.
Publicado: (2018)

A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With anSDHC Germline Mutation
por: Ong, Raquel Kristin S, et al.
Publicado: (2018)

Correction: Tumour risks and genotype-phenotype correlations associated with germline variants in the succinate dehydrogenase subunit genes SDHB, SDHC, and SDHD
Publicado: (2019)

Ripretinib: First Approval
por: Dhillon, Sohita
Publicado: (2020)

A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL
por: Bourdeau, Isabelle, et al.
Publicado: (2016)

Correction to: Ripretinib: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Ripretinib for gastrointestinal stromal tumours
Publicado: (2021)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2006)

Rare deleterious germline variants and risk of lung cancer
por: Liu, Yanhong, et al.
Publicado: (2021)

OR08-05 Case Series Of French Canadian Patients With Paragangliomas Carrying The c.397C>T SDHC Mutation: Insights On SDHC Phenotype And Outcomes
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2023)

Ripretinib for the treatment of advanced gastrointestinal stromal tumor
por: Zalcberg, John R.
Publicado: (2021)

SDHC methylation in gastrointestinal stromal tumors (GIST): a case report
por: Urbini, Milena, et al.
Publicado: (2015)

Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas
por: De Sousa, Sunita M C, et al.
Publicado: (2020)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward
por: Lostes-Bardaji, M. Julia, et al.
Publicado: (2021)

Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
por: Janku, F., et al.
Publicado: (2022)

Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
por: Esai Selvan, Myvizhi, et al.
Publicado: (2023)

SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice
por: Casey, Ruth T., et al.
Publicado: (2019)

Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies
por: Godley, Lucy A.
Publicado: (2023)

Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
por: Thirasastr, Prapassorn, et al.
Publicado: (2023)

Prevalence of deleterious ATM germline mutations in gastric cancer patients
por: Huang, Dong-Sheng, et al.
Publicado: (2015)

Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM)
por: Ciach, Katarzyna, et al.
Publicado: (2016)

Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
por: de Voer, Richarda M., et al.
Publicado: (2015)

Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming
por: Iqbal, Khursheed, et al.
Publicado: (2015)

Mitochondrial fragmentation drives selective removal of deleterious mtDNA in the germline
por: Lieber, Toby, et al.
Publicado: (2019)

Novel approaches to treating advanced systemic mastocytosis
por: Gilreath, JA, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
por: Liao, Weiting, et al.
Publicado: (2021)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
por: Wang, Hui-jun, et al.
Publicado: (2021)

Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib
por: Brackert, Sandra, et al.
Publicado: (2023)

Deleterious alleles in the context of domestication, inbreeding, and selection
por: Bosse, Mirte, et al.
Publicado: (2018)

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
por: Ellingson, Marissa S., et al.
Publicado: (2015)

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2021)

Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience
por: Desai, Ami V., et al.
Publicado: (2017)

Making life difficult for Clostridium difficile: augmenting the pathogen’s metabolic model with transcriptomic and codon usage data for better therapeutic target characterization
por: Kashaf, Sara Saheb, et al.
Publicado: (2017)

COVID-19 and comorbidities: Deleterious impact on infected patients
por: Ejaz, Hasan, et al.
Publicado: (2020)

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_329mif881c6fv52s8vr8qaurda